Trajectories of childhood immune development and respiratory health relevant to asthma and allergy

  1. Howard HF Tang  Is a corresponding author
  2. Shu Mei Teo
  3. Danielle CM Belgrave
  4. Michael D Evans
  5. Daniel J Jackson
  6. Marta Brozynska
  7. Merci MH Kusel
  8. Sebastian L Johnston
  9. James E Gern
  10. Robert F Lemanske
  11. Angela Simpson
  12. Adnan Custovic
  13. Peter D Sly
  14. Patrick G Holt
  15. Kathryn E Holt
  16. Michael Inouye  Is a corresponding author
  1. Baker Heart and Diabetes Institute, Australia
  2. Imperial College London, United Kingdom
  3. University of Wisconsin School of Medicine and Public Health, United States
  4. University of Western Australia, Australia
  5. University of Manchester, United Kingdom
  6. The University of Melbourne, Australia
  7. University of Cambridge, United Kingdom

Abstract

Events in early life contribute to subsequent risk of asthma; however, the causes and trajectories of childhood wheeze are heterogeneous and do not always result in asthma. Similarly, not all atopic individuals develop wheeze, and vice versa. The reasons for these differences are unclear. Using unsupervised model-based cluster analysis, we identified latent clusters within a prospective birth cohort with deep immunological and respiratory phenotyping. We characterised each cluster in terms of immunological profile and disease risk, and replicated our results in external cohorts from the UK and USA. We discovered three distinct trajectories, one of which is a high-risk 'atopic' cluster with increased propensity for allergic diseases throughout childhood. Atopy contributes varyingly to later wheeze depending on cluster membership. Our findings demonstrate the utility of unsupervised analysis in elucidating heterogeneity in asthma pathogenesis and provide a foundation for improving management and prevention of childhood asthma.

Data availability

This study utilises extensive data from human subjects, specifically paediatric cohorts, for which eLife's policies recognise that there can be strong reasons to restrict access. For each of the cohorts involved in our study (CAS, COAST, MAAS), parents were consented on the use of biomedical data for allergy and asthma research, but not for the open sharing of their or their children's data. Studies were run in the late 1990s and early 2000s and we do not have ethics permission to attempt to recontact families to seek consent. Importantly, we note that key data features could risk re-identification of subjects (e.g. demographic data from small communities).However, we have provided public data at the summary level which can be used for subsequent studies, such as replication and meta-analysis. This is standard practice in sensitive data settings, such as genome-wide association studies. These data have been uploaded as Excel spreadsheets to FigShare for ease of data extraction:Supplementary Table 4 https://figshare.com/articles/Supplementary_File_1_1/6934052Supplementary Table 7 https://figshare.com/articles/Supplementary_File_1_2/6934055

Article and author information

Author details

  1. Howard HF Tang

    Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia
    For correspondence
    Howard.Tang@baker.edu.au
    Competing interests
    The authors declare that no competing interests exist.
  2. Shu Mei Teo

    Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Danielle CM Belgrave

    Department of Paediatrics, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Michael D Evans

    University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7449-3993
  5. Daniel J Jackson

    University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Marta Brozynska

    Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Merci MH Kusel

    Telethon Kids Institute, University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Sebastian L Johnston

    Airway Disease Infection Section, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. James E Gern

    University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Robert F Lemanske

    University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Angela Simpson

    Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Adnan Custovic

    Department of Paediatrics, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5218-7071
  13. Peter D Sly

    Telethon Kids Institute, University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  14. Patrick G Holt

    Telethon Kids Institute, University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  15. Kathryn E Holt

    Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  16. Michael Inouye

    Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    mi336@medschl.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9413-6520

Funding

National Health and Medical Research Council (1049539)

  • Michael Inouye

National Health and Medical Research Council (PhD Scholarship)

  • Howard HF Tang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. M Dawn Teare, University of Sheffield, United Kingdom

Ethics

Human subjects: Ethics approval and consent requirements for each cohort were met as follows: The CAS study was approved by the ethics committees of the King Edward Memorial and Princess Margaret Hospitals in Western Australia; fully informed parental consent was obtained for all subjects. The COAST study was approved by the Human Subjects Committee of the University of Wisconsin. The MAAS study was approved by a Manchester Local Research Ethics Committee (ERP/94/032; SOU/00/258; 03/SM/400; Study registration ISRCTN72673620); fully informed parental consent was obtained for all subjects across all cohorts.

Version history

  1. Received: February 12, 2018
  2. Accepted: October 5, 2018
  3. Accepted Manuscript published: October 15, 2018 (version 1)
  4. Version of Record published: November 7, 2018 (version 2)

Copyright

© 2018, Tang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,907
    views
  • 282
    downloads
  • 21
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Howard HF Tang
  2. Shu Mei Teo
  3. Danielle CM Belgrave
  4. Michael D Evans
  5. Daniel J Jackson
  6. Marta Brozynska
  7. Merci MH Kusel
  8. Sebastian L Johnston
  9. James E Gern
  10. Robert F Lemanske
  11. Angela Simpson
  12. Adnan Custovic
  13. Peter D Sly
  14. Patrick G Holt
  15. Kathryn E Holt
  16. Michael Inouye
(2018)
Trajectories of childhood immune development and respiratory health relevant to asthma and allergy
eLife 7:e35856.
https://doi.org/10.7554/eLife.35856

Share this article

https://doi.org/10.7554/eLife.35856

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Weichen Song, Yongyong Shi, Guan Ning Lin
    Tools and Resources

    We propose a new framework for human genetic association studies: at each locus, a deep learning model (in this study, Sei) is used to calculate the functional genomic activity score for two haplotypes per individual. This score, defined as the Haplotype Function Score (HFS), replaces the original genotype in association studies. Applying the HFS framework to 14 complex traits in the UK Biobank, we identified 3619 independent HFS–trait associations with a significance of p < 5 × 10−8. Fine-mapping revealed 2699 causal associations, corresponding to a median increase of 63 causal findings per trait compared with single-nucleotide polymorphism (SNP)-based analysis. HFS-based enrichment analysis uncovered 727 pathway–trait associations and 153 tissue–trait associations with strong biological interpretability, including ‘circadian pathway-chronotype’ and ‘arachidonic acid-intelligence’. Lastly, we applied least absolute shrinkage and selection operator (LASSO) regression to integrate HFS prediction score with SNP-based polygenic risk scores, which showed an improvement of 16.1–39.8% in cross-ancestry polygenic prediction. We concluded that HFS is a promising strategy for understanding the genetic basis of human complex traits.

    1. Computational and Systems Biology
    Qianmu Yuan, Chong Tian, Yuedong Yang
    Tools and Resources

    Revealing protein binding sites with other molecules, such as nucleic acids, peptides, or small ligands, sheds light on disease mechanism elucidation and novel drug design. With the explosive growth of proteins in sequence databases, how to accurately and efficiently identify these binding sites from sequences becomes essential. However, current methods mostly rely on expensive multiple sequence alignments or experimental protein structures, limiting their genome-scale applications. Besides, these methods haven’t fully explored the geometry of the protein structures. Here, we propose GPSite, a multi-task network for simultaneously predicting binding residues of DNA, RNA, peptide, protein, ATP, HEM, and metal ions on proteins. GPSite was trained on informative sequence embeddings and predicted structures from protein language models, while comprehensively extracting residual and relational geometric contexts in an end-to-end manner. Experiments demonstrate that GPSite substantially surpasses state-of-the-art sequence-based and structure-based approaches on various benchmark datasets, even when the structures are not well-predicted. The low computational cost of GPSite enables rapid genome-scale binding residue annotations for over 568,000 sequences, providing opportunities to unveil unexplored associations of binding sites with molecular functions, biological processes, and genetic variants. The GPSite webserver and annotation database can be freely accessed at https://bio-web1.nscc-gz.cn/app/GPSite.